Despite ERBB2 being a well-known oncogene and regarded as a crucial diagnostic/prognostic biomarker and therapeutic target in multiple tumors, such as breast cancer (Wynn and Tang, 2022), the exact function of ERBB2 in tumors remains largely unknown. Here, ERBB2 is linked to breast cancer.